A new oral insulin embedded in sugar-free chocolate uses nano-carriers to target the liver, cutting hypoglycemia risk. The ...
RFK Jr. recently added peptide-friendly members to a key panel ...
Eisai Co., Ltd. announced today the company will present the latest findings from its Alzheimer’s disease (AD) research, including lecanem ...
Backed by data from the phase 3 SatraGO trials, satralizumab has the potential to offer patients a convenient, at-home treatment option.
Researchers have discovered two vulnerabilities in the widely used Cursor AI-enabled integrated development environment (IDE) ...
Scientists usually use animal models when studying Parkinson's disease because these models mimic the disease well. They are ...
Scientists at The Wistar Institute have shown that a single injection of a small, circular piece of genetic instruction can ...
Two critical Cursor IDE vulnerabilities, dubbed DuneSlide, let prompt injection break the editor's command sandbox with no ...
Immune checkpoint inhibitors like anti-PD-1 have transformed melanoma treatment, yet more than half of patients fail to ...